🟢 100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 38% of ingredients have research evidence
A Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

3 Capsule(s) Serving Size
30 Servings
Other Combinations Product Type
38% Evidence Coverage

Supplement Facts — Evidence Check

Cordyceps
750 mg
Propolis
300 mg
📊 Market median: 250.0mg (337 products) 📚 125 studies (Tier A: 1, B: 41)
This product: 300mg
📊 Market median: 470.0mg (230 products) 📚 9 studies (Tier A: 3, B: 3)
This product: 250mg
Adhatoda Extract
250 mg
📊 Market median: 375.0mg (171 products) 📚 30 studies (Tier A: 1, B: 14)
This product: 250mg
250 mg
📊 Market median: 200.0mg (136 products) 📚 3 studies — no high-quality reviews
This product: 250mg
Vinpocetine
15 mg

Other Ingredients

Microcrystalline Cellulose Vegetable Stearate

Label Claims — Verification

All Other
All Other (100% of products) Structure/Function (81% of products) Nutrient (3% of products)

Target Groups

Adult (18 - 50 Years) Gluten Free

Product Information

📋 Directions for Use

Recommended Use: As a dietary supplement, take three capsules per day, or as directed by your health care practitioner.

⚠️ Warnings & Precautions

KEEP OUT OF REACH OF CHILDREN.

🧪 Formulation Notes

Does not contain gluten.

Additional Information

Notice: Color, size or shape may appear different between lots.

PRV090

For Professional Use Only

Guaranteed GMP COMPLIANT Products

STORE IN A COOL, DRY PLACE.

Manufactured in an NSF GMP Registered Facility

Product Details

UPC / SKU 8 79452 00370 5
DSLD Entry Date 2013-06-25
Product Type Other Combinations
Form Capsule
DSLD ID 23247
Data Updated 2026-04-11

Research Evidence

9 Research Sources
60 Avg Quality Score
5 Meta Analysis
2 Cochrane Review
1 Systematic Review
1 Rct
B Astragalus (a traditional Chinese medicine) for treating chronic kidney disease.
Cochrane Review The Cochrane database of systematic reviews
B Oral Astragalus (Huang qi) for preventing frequent episodes of acute respiratory tract infection in children.
Cochrane Review The Cochrane database of systematic reviews
B Evaluating traditional Chinese medicine (TCM) Jie Geng and Huang Qi combination on reducing surgical site infections in colorectal cancer surgeries: A systematic review and meta-analysis
Meta Analysis International wound journal 2024
B Chronic fatigue syndrome post-COVID-19: triple-blind randomised clinical trial of Astragalus root extract
Rct BMJ supportive & palliative care 2025
B Efficacy and potential pharmacological mechanism of Astragalus-Salvia miltiorrhiza combination in diabetic nephropathy: integrating meta-analysis, network pharmacology, molecular docking, and experimental validation
Meta Analysis Renal failure 2025
B Renal protective effects and mechanisms of Astragalus membranaceus for diabetic kidney disease in animal models: An updated systematic review and meta-analysis
Meta Analysis Phytomedicine : international journal of phytotherapy and phytopharmacology 2024
C Adjuvant therapy with Astragalus membranaceus for post-stroke fatigue: a systematic review
Systematic Review Metabolic brain disease 2020
C Efficacy of Astragalus Membranaceus (Huang Qi) for Cancer-Related Fatigue: A Systematic Review and Meta-Analysis of Randomized Controlled Studies
Meta Analysis Integrative cancer therapies 2025
C The Effect of Astragalus on Humoral and Cellular Immune Response: A Systematic Review and Meta-Analysis of Human Studies
Meta Analysis Complementary medicine research 2023
View all evidence for Astragalus →

Compare Similar Products

View all Astragalus products →